Shree Hari Chemicals Export Ltd’s Mixed Week: -0.33% Price Change Amid Valuation Shift and Downgrade

1 hour ago
share
Share Via
Shree Hari Chemicals Export Ltd closed the week ending 31 July 2026 marginally lower by 0.33%, finishing at ₹134.50 compared to the previous Friday’s close of ₹134.95. This underperformance contrasted with the broader Sensex, which advanced 2.39% over the same period, reflecting a divergence between the stock’s price action and the overall market rally. The week featured a valuation upgrade followed by a downgrade in rating, underscoring mixed signals from financial and technical perspectives.

Key Events This Week

27 Jul: Stock opens strong at ₹136.45 (+1.11%) alongside Sensex gains

30 Jul: Valuation upgraded to Very Attractive amid sector volatility

31 Jul: Mojo Grade downgraded to Sell due to mixed financial and technical signals

31 Jul: Week closes at ₹134.50 (-0.33%) despite Sensex rally

Week Open
Rs.134.95
Week Close
Rs.134.50
-0.33%
Week High
Rs.136.45
vs Sensex
-2.72%

27 July 2026: Positive Start Amid Market Rally

Shree Hari Chemicals Export Ltd began the week on a positive note, closing at ₹136.45, up ₹1.50 or 1.11% from the previous close. This gain was in line with the Sensex’s robust 1.05% advance to 36,207.16 points. The stock’s volume of 945 shares indicated moderate trading interest. The positive momentum reflected early optimism, possibly driven by sector dynamics and the broader market’s strength.

28-29 July 2026: Profit Taking and Market Volatility

The stock reversed course on 28 July, declining 1.06% to ₹135.00 on subdued volume of 258 shares, while the Sensex slipped marginally by 0.14%. The following day, 29 July, saw a further dip of 0.63% to ₹134.15 despite the Sensex rebounding strongly by 1.02% to 36,524.95. This divergence suggested selective profit-taking in the stock amid broader market gains. Volume picked up to 721 shares, indicating renewed investor activity but with a cautious stance.

30 July 2026: Valuation Upgrade Highlights Attractive Pricing

On 30 July, Shree Hari Chemicals Export Ltd’s valuation metrics were upgraded to “Very Attractive” amid sector volatility. The stock closed unchanged at ₹134.15, with a trading range between ₹130.50 and ₹137.00. Key valuation ratios included a price-to-earnings (P/E) of 20.69 and price-to-book value (P/BV) of 1.92, positioning the stock favourably against peers such as J.G. Chemicals (P/E 30.11) and Titan Biotech (P/E 57.88). The enterprise value to EBITDA ratio stood at 16.82, reflecting moderate operational earnings relative to enterprise value.

This re-rating was supported by the company’s strong relative price performance over longer horizons, including a 25.96% return over the past month and a three-year gain of 181.41%, significantly outperforming the Sensex. Despite modest profitability metrics—ROCE at 6.07% and ROE at 9.30%—the valuation upgrade suggested growing investor recognition of the stock’s value proposition within the commodity chemicals sector.

Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!

  • - Just announced pick
  • - Pre-market insights shared
  • - Tyres & Allied weekly focus

Get Pre-Market Insights →

31 July 2026: Downgrade to Sell Amid Mixed Signals

Despite the attractive valuation, Shree Hari Chemicals Export Ltd was downgraded to a “Sell” rating by MarketsMOJO on 30 July, reflecting concerns over mixed financial and technical signals. The latest quarterly results showed flat net sales of ₹41.22 crores for Q4 FY25-26, a 7.5% decline from the previous four-quarter average. Return on capital employed (ROCE) dipped to 9.50%, and non-operating income accounted for an outsized 161.72% of profit before tax, indicating reliance on irregular income streams.

Technically, the outlook shifted from bullish to mildly bullish, with weekly MACD remaining positive but monthly MACD turning mildly bearish. The weekly Relative Strength Index (RSI) was bearish, while monthly RSI was neutral. Bollinger Bands suggested mild to full bullishness depending on timeframe, and moving averages on the daily chart remained bullish. However, the mixed technical indicators contributed to the cautious stance.

The stock closed the week at ₹134.50, up 0.26% on the day but down 0.33% for the week, underperforming the Sensex’s 2.39% gain. Insider buying by the promoter group increased their stake by 5.01% to 64.26%, signalling confidence despite operational challenges. The downgrade to “Sell” accompanied a lowered Mojo Score of 47.0, reflecting the complex investment profile of this micro-cap commodity chemicals firm.

Holding Shree Hari Chemicals Export Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Daily Price Performance vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-07-27 Rs.136.45 +1.11% 36,207.16 +1.05%
2026-07-28 Rs.135.00 -1.06% 36,155.32 -0.14%
2026-07-29 Rs.134.15 -0.63% 36,524.95 +1.02%
2026-07-30 Rs.134.15 +0.00% 36,541.96 +0.05%
2026-07-31 Rs.134.50 +0.26% 36,684.83 +0.39%

Key Takeaways

Positive Signals: The valuation upgrade to “Very Attractive” on 30 July highlighted the stock’s relative affordability compared to peers, supported by reasonable P/E and P/BV ratios. Long-term price performance remains robust, with three-year returns exceeding 180%, and insider buying by promoters signals confidence in the company’s prospects.

Cautionary Signals: The downgrade to “Sell” reflects concerns over flat recent financial results, declining profitability metrics, and mixed technical indicators. Reliance on non-operating income and a modest ROCE of 6.07% suggest operational challenges. The stock’s underperformance relative to the Sensex during the week further emphasises near-term headwinds.

Conclusion

Shree Hari Chemicals Export Ltd’s week was marked by contrasting developments. While valuation metrics improved, signalling potential value for investors, the downgrade in rating and mixed financial and technical signals counsel caution. The stock’s micro-cap status adds volatility and risk, making it a complex proposition. Investors should carefully weigh the attractive valuation against operational uncertainties and technical ambiguity before considering exposure. The divergence between the stock’s price movement and the Sensex’s strong weekly gain underscores the nuanced outlook for this commodity chemicals player.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News